Skip to main content
Caplight Logo









Aphios Corporation

Aphios Corporation

Private
Woburn, MassachusettsHealthcare & Life Scienceshttps://www.aphios.com/

Last Round

Grant

Dec 11, 2024

Est. Valuation

$70.09M

Total Funding Raised

$4.06M

Company Overview

Aphios Corporation is a biopharmaceutical company that develops enhanced therapeutics for health maintenance and the treatment of human diseases with a focus on infectious diseases, cancer, and central nervous system (CNS) disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Biotech Equipment

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

supercritical fluid extractionnanotechnology drug deliverynatural product drugsnanomedicinedrug discovery platformtechnology licensingpathogen safetycancer therapeuticsAlzheimer's therapeuticsHIV therapeuticsgreen manufacturingtargeted drug deliverySBIR grantsbotanical drugsiRNA therapeuticscannabis-based therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aphios Corporation Comparables

Compare Aphios Corporation with similar companies based on industry and business-model similarity.

Aphios Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
StaniPharm
77%
Nanoform Finland Oyj
74%
Crystec Pharma
72%

Aphios Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 11, 2024
GrantSep 20, 2024
GrantSep 6, 2023
GrantMar 3, 2023
CrowdfundingJul 31, 2022
Crowdfunding
Dec 31, 2019

Aphios Corporation Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 11, 2024

    $505K grant round led by National Institute on Aging.

  • Sep 20, 2024

    $416K grant from National Center for Complementary and Integrative Health.

Aphios Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aphios Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aphios Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersWoburn, Massachusetts
Year Founded1993
Last FundingDec 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?